Proudfoot CW, Alnwick K Heron Evidence Development Ltd, Letchworth Garden City, UK OBJECTIVES: Quality-adjusted life-years (QALYs) measure the number of years of perfect health provided by a health care intervention, and are a useful measure because they combine mortality and morbidity in one scale. QALYS are considered the "gold-standard" for assessing the effectiveness, and thus costeffectiveness, of new interventions and are requested by most reimbursement agencies, such as the UK NICE. Utility data (generally gained through quality-of-life instruments) are required to calculate QALYs, however such data may not be available for some drug indications. As a result, these drug indications are not suitable for assessment via QALYs. We sought to clarify the extent to which this is a problem. METHODS: We reviewed all prescription drugs (including new preparations of existing drugs) approved by the UK regulatory agency, the MHRA. Using an online database of utility scores from Tufts University, we conducted various descriptive analyses. Our primary analysis was to establish the percentage of licensed drugs for which utility scores are available and thus for which QALYs are a possible effectiveness measure. RESULTS: Interim analysis of 93 licensed preparations showed that 73% had utility data available. This leaves a substantial proportion of drugs for which QALYs may be difficult or impossible to obtain. Where QALYs are difficult to obtain, this may limit the confidence with which they can be interpreted. In other cases, QALYs may be irrelevant: these include important indications such as anaesthesia and contraception. CONCLU-SIONS: It is important for reimbursement agencies to recognise that QALYs are not a universal measure, and that flexibility is required for indications in which QALYs cannot be used. An over-emphasis on QALYs may lead to a bias against positive recommendations in disease areas where QALYS cannot be used.
PMC46 SHOULD WE BE CONSIDERING COMPONENTS OF SOCIAL COGNITION MODELS TO IMPROVE ADHERENCE TO IMMUNOSUPPRESSION MEDICATION?
Reaney MD 1 , Martin C 2 , Speight J 1 1 AHP Research, Uxbridge, UK, 2 University of the West of Scotland, Ayr, UK OBJECTIVES: Influential health psychology models consider the social context of health beliefs and their influence on medication uptake and adherence. We conducted a systematic literature review to identify how widely three social cognition models have been used in transplantation and whether consideration of such psychological factors can improve adherence to immunosuppression therapy and, consequently, the success of the transplantation. METHODS: Systematic searches were undertaken in SCOPUS. Three social cognition models (Health Belief Model (HBM), Theory of Reasoned Action (TRA), and Social Learning Theory (SLT)) were paired with the search terms "transplant*" and "immunosuppress*" in a fully inclusive search (since 1966).
RESULTS:
The HBM has been used only once in transplant research, related to adherence with immunosuppression regimens in kidney transplant (N = 110). The study concluded that interventional strategies to increase adherence will need to consider the variables of the HBM in order to maximise success. The TRA has been used only twice in transplantation, on both occasions in the general population to elicit views on organ donation. One study (N = 298) examined reluctance to discuss organ donation with family members. Intentions, attitudes, subjective norms, death anxiety, and knowledge were important when reducing communication barriers. The aim of the second study was to investigate knowledge, behaviour and normative beliefs of students concerning transplant and organ donations, based on the TRA (N = 94). SLT has not been explored in transplantation but is highlighted as a valid method for providing professional support to live kidney donors before and after surgery. CON-CLUSIONS: Social cognition models include a variety of psychological factors that can aid our understanding of medication adherence. However, they have not been used widely in transplant populations. Use of such models can encourage discussion about sensitive issues surrounding organ donation and is likely to maximise adherence to immunosuppression medication for those undergoing transplantation.
PMC47 A STUDY OF THE KEY FACTORS INFLUENCING THE PATIENT SATISFACTION IN INPATIENT AND OUTPATIENT SETTINGS
Tsai SF, Yeh GC Taipei Medical University Hospital, Taipei, Taiwan OBJECTIVES: This study was conducted in April 2007 at the Taipei Medical University Hospital, which is a district teaching hospital in Taiwan. The purpose of this study is to identify the most important determinants of the Patient satisfaction in the inpatient and outpatient settings. METHODS: Patient satisfaction was measured in a self written survey of inpatient and outpatient setting with the structured questionnaire including demography, environment, service manner, administration efficiency, process of diagnosis and treatment. This study collected data of 201 outpatient and 186 inpatient and were analysed with SPSS package. Stepwise regression analysis were conducted to help identify which factors were the most important in determining and chosen to make the best predicting model for patient satisfaction. RESULTS: Patients were generally satisfied with the mean score 4.12 and 3.77 in inpatient and outpatient respectively (scale 1 to 5, 5 being most satisfied). Through the stepwise regression analysis, in inpatient setting, the best fit for patient satisfaction standardized predicting model is : The PROLabels database (www.mapi-prolabels. org) was developed to provide easy access to Patient-Reported Outcomes (PROs) included in approved labeling of products in Europe and the USA. Two years after its launch, the coverage of FDA labels has been extended to give a more comprehensive image of the current use of PROs in clinical studies.
METHODS:
In 2006, the database opened with drugs approved in Europe through the centralized procedure established by the EMEA in January 1995 and with New Molecular Entities (NME) approved in the USA since January 1998. The extension project focused on other chemical types approved by FDA (e.g. New dosage form, New combination, etc.) and on NME approved before 1998. Once a PRO claim was identified in a label, the drug was added in PROLabels and the following information was retrieved: the PRO claim, description of clinical studies supporting the claim, description of PRO endpoints and measures used, pharmacological action of products and information source. RESULTS: Updated figures resulting from this major extension of PROLabels will be presented. These new figures will include the number of drug products present in the database with the FDA/EMEA distribution, the most represented therapeutic areas (currently nervous system diseases: 27.8%, immune system diseases: 20.6%, respiratory tract diseases: 16.5%, pathological conditions, signs and symptoms: 14.9%, and mental disorders: 14.6%), and the most frequently measured PROs (currently Signs and Symptoms followed by Health-Related Quality of Life (HRQL)). Finally, any change in the rate of PRO data found overall in FDA approvals will be checked. CONCLUSIONS: This extension of the FDA coverage of the PROLabels database allows a clearer picture of the use of PROs to assess patients' treatment benefit to be drawn. In addition, it facilitates the examination of the discrepancies between the US and European regulatory agencies. (HLC) is associated with health-related behaviors such as adherence and participation in health screening. However, HLC among physicians may be different from that among the general public. It is important to understand the potential gap in HLC between physicians and the general public. The aim of the study included two steps: 1) to evaluate item bias of the HLC scale between physicians and the general public, and 2) to characterize HLC among physicians compared to the general public. METHODS: Data for the general public were obtained from the health diary study that involved a random sample from a nationally representative group of households in Japan. Physicians' data were collected from a web-based survey of Japanese physicians. Multi-group structural equation modeling was used for examining item bias in the Japanese version of the HLC scale (HLCS-J) between the two groups. Differential item functioning (DIF), including uniform and non-uniform types, were used for measuring item bias. Dimensions with no uniform and non-uniform DIFs were then compared using multiple linear regressions. RESULTS: Data on the HLCS-J of 2194 people from the general public and 895 physicians were available. Uniform DIF was recognized for the dimensions of internal, professional control and control by spiritual powers. Chance and family control dimensions had no DIF. Mean score for chance control (17.2) among physicians was greater than that (14.9) among the general public (adjusted p < 0.001), while mean score for family control (21.7) among physicians was lower than that (22.1) among the general public (adjusted p < 0.001). CONCLUSIONS: Our psychometric evaluation of the HLCS-J indicates item bias in the dimensions of internal, professional control and control by spiritual powers. Physicians believe that chance has a greater impact but family control has a lesser impact on health than do members of the general public. The VAS is a common response scale in PRO questionnaires, which are used in multinational studies from which data is pooled. This study was designed to evaluate the suitability of VAS for use in different international settings, specifically to evaluate the cognitive processes and challenges occurring when respondents from a range of countries/cultures complete VAS. METHODS: Adults were recruited from: UK; Mexico; Spain; Malaysia; India; South Africa, with approximately 50:50 males/females and higher/lower education split. Each completed four VAS followed by a cognitive debriefing interview, once before and once after receiving standardized instructions. RESULTS: Thirty-seven lay persons were interviewed across 6 countries, mean age was 46 Ϯ 19; 51.4% were male. Several respondents commented on the unfamiliar style of the VAS. Some reported the anchors as inappropriate/ambiguous, impeding scale completion, or that anchor wording caused them to avoid scale extremities. Respondents noted the lack of intermediate markers on the VAS, therefore having to rely on 'guesswork': most used quantitative rather than qualitative strategies when deciding where to place their mark. Some had concerns that 'guesswork' led to inaccurate responses. British and Spanish respondents used principally quantitative methods whereas Zulu speakers relied more on qualitative techniques. Respondents from Malaysia, South Africa and India were more inclined to report challenges; Zulu and Tamil speakers completed the VAS in the least conventional way. CONCLUSIONS: The study provides substantial evidence that the use of VAS in different international
PMC49 COMPARISON OF HEALTH LOCUS OF CONTROL BETWEEN PHYSICIANS AND THE GENERAL PUBLIC: MULTI-GROUP STRUCTURAL EQUATION MODELING
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